4-Hydroxytamoxifen is used in multi-dose regimens in a number of indications including hyperplasia of the breast, infertility, early and advanced estrogen receptor-positive breast cancer, gynecomastia, and peripheral precocious puberty. The gene discussed is ESR1; the disease is breast hyperplasia.